• P112H -Human K-ras Gene Mutation Detection Kit
  • P112H -Human K-ras Gene Mutation Detection Kit
  • P112H -Human K-ras Gene Mutation Detection Kit

P112H -Human K-ras Gene Mutation Detection Kit

Type: IVD Reagent
Spec: 25T
Transport Package: Paper Carton with Icy Bag
Specification: 44*44*45 cm
Trademark: Tianlong
Origin: Suzhou
Samples:
US$ 100/Box 1 Box(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Parameters
  • Tianlong PCR Kit List
  • Company Profile
  • Why Choose Tianlong?
  • Our Achievement
Overview

Basic Info.

Model NO.
P112H
HS Code
3822009000
Production Capacity
5000000 Test/Year

Product Description

Product Description

Product Name: 
Human K-ras Gene Mutation Detection Kit (PCR-Melting Curve Method)

Intended Use:

The kit uses genomic DNA extracted from tumor paraffin-embedded tissue sections of human non-small cell lung cancer and colorectal cancer as test samples for qualitative detection of 12 somatic mutations at codon 12 and 13 of K-ras gene .

K-ras gene, located on chromosome 12p12.1, is one of the important oncogenes. It encodes a 21kD KRAS protein and participates in intracellular signal transduction, mainly including RAS/PI3K/PTEN/ Akt and RAS/RAF/MEK/ERK signal transduction pathway. These transduction pathways are currently the hotspots in the research of tumor-targeted drugs. Targeted drugs have pharmacological effects by inhibiting these pathways. Studies have shown that K-ras gene mutations exist in non-small cell lung cancer and colorectal cancer, and mutation of K-ras occurring at codon 12 and 13 which could cause KRAS protein to mutate and remain activated can render the drug ineffective.

According to the 2010 edition of the Chinese Oncology Clinical Practice Guidelines, 101 patients with bronchioloalveolar carcinoma of the lung adenocarcinoma subtype received first-line treatment with erlotinib alone in a retrospective study. The results showed that no one (0/18) achieved remission in K-ras mutation group, while 20 (20/62, 32%) had remission in non-K-ras mutation group (P<0.01). Therefore, the guidelines recommend that patients with non-small cell lung cancer and colorectal cancer should detect mutation of K-ras before using targeted drugs. This product is suitable for patients with non-small cell lung cancer and colorectal cancer before entering the individualized targeted therapy course, and provides auxiliary diagnostic evidence for the individualized medication of clinical tumor-targeted drugs.

 

Product Parameters

Product Name Human K-ras Gene Mutation Detection Kit (PCR-Melting Curve Method)
Cat.No P112H
Specification 20T/Kit 
Specimen paraffin-embedded tissue sections of human non-small cell lung cancer and colorectal cancer
Storage & Validity It shall be stored at -20ºC±5ºC in a dark place, and is valid for 12 months. Repeated freezing and thawing shall be avoided.
Applicable Equipment ABI7500 real time PCR systems, Gentier96E/ Gentier96R/Gentier48E/ Gentier48R  Real-time PCR System from Xi'an Tianlong Science and Technology Co., Ltd.

 

 

Tianlong PCR Kit List

 

P112H -Human K-ras Gene Mutation Detection KitP112H -Human K-ras Gene Mutation Detection KitP112H -Human K-ras Gene Mutation Detection Kit
 

Company Profile

P112H -Human K-ras Gene Mutation Detection KitP112H -Human K-ras Gene Mutation Detection KitP112H -Human K-ras Gene Mutation Detection KitP112H -Human K-ras Gene Mutation Detection Kit

Why Choose Tianlong?

P112H -Human K-ras Gene Mutation Detection Kit

Our Achievement

 

P112H -Human K-ras Gene Mutation Detection Kit

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
62020000 RMB
Plant Area
20000 square meters